| Copper induces cell death by targeting lipoylated TCA cycle proteins P Tsvetkov, S Coy, B Petrova, M Dreishpoon, A Verma, M Abdusamad, ... Science 375 (6586), 1254-1261, 2022 | 2449 | 2022 |
| Discovering the anticancer potential of non-oncology drugs by systematic viability profiling SM Corsello, RT Nagari, RD Spangler, J Rossen, M Kocak, JG Bryan, ... Nature cancer 1 (2), 235-248, 2020 | 609 | 2020 |
| Mitochondrial metabolism promotes adaptation to proteotoxic stress P Tsvetkov, A Detappe, K Cai, HR Keys, Z Brune, W Ying, P Thiru, ... Nature chemical biology 15 (7), 681-689, 2019 | 386 | 2019 |
| Massively parallel pooled screening reveals genomic determinants of nanoparticle delivery N Boehnke, JP Straehla, HC Safford, M Kocak, MG Rees, M Ronan, ... Science 377 (6604), eabm5551, 2022 | 121 | 2022 |
| Non-oncology drugs are a source of previously unappreciated anti-cancer activity SM Corsello, RT Nagari, RD Spangler, J Rossen, M Kocak, JG Bryan, ... BioRxiv, 730119, 2019 | 38 | 2019 |
| Safepredict: A meta-algorithm for machine learning that uses refusals to guarantee correctness MA Kocak, D Ramirez, E Erkip, DE Shasha IEEE Transactions on Pattern Analysis and Machine Intelligence 43 (2), 663-678, 2019 | 20 | 2019 |
| Author Correction: Mitochondrial metabolism promotes adaptation to proteotoxic stress P Tsvetkov, A Detappe, K Cai, HR Keys, Z Brune, W Ying, P Thiru, ... Nature chemical biology 15 (7), 757, 2019 | 10 | 2019 |
| Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069 DL Orsi, E Pook, N Bräuer, A Friberg, P Lienau, CT Lemke, T Stellfeld, ... Journal of medicinal chemistry 65 (21), 14843-14863, 2022 | 7 | 2022 |
| Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling. Nat Cancer. 2020; 1: 235–48 SM Corsello, RT Nagari, RD Spangler, J Rossen, M Kocak, JG Bryan | 7 | 2022 |
| Conjugate Conformal Prediction for Online Binary Classification. MA Koçak, DE Shasha, E Erkip UAI, 2016 | 5 | 2016 |
| Glycosylated haemoglobins in advanced malignancy. M Koçak, LJ Hipkin, JC Davis European Journal of Cancer 17 (1), 123-124, 1981 | 3 | 1981 |
| On the design of preamble for autonomous communications with extended coverage MA Kocak, K Balachandran, JH Kang, K Karakayali, KM Rege 2017 IEEE 85th Vehicular Technology Conference (VTC Spring), 1-5, 2017 | 2 | 2017 |
| Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition NAM Shendy, M Bikowitz, LH Sigua, Y Zhang, A Mercier, Y Khashana, ... Nature Communications 15 (1), 3483, 2024 | 1 | 2024 |
| Abstract PR004: PRISM high-throughput screening of antibody-drug conjugates uncovers clinically relevant targets JN Eskra, E Nguyen, A Golabi, S Nair, A Masciotti, A Fazio, M Kocak, ... Molecular Cancer Therapeutics 22 (12_Supplement), PR004-PR004, 2023 | 1 | 2023 |
| Adenosine receptor antagonists exhibit potent and selective off-target killing of FOXA1-high cancers SM Corsello, RD Spangler, R Humeidi, CN Harrington, RT Nagari, ... Cancer Research 80 (16_Supplement), 3400-3400, 2020 | 1 | 2020 |
| Optimizing 500 pooled PRISM cell lines for a 10-day assay to elucidate viability effects and mechanism of action for slower-acting therapeutics M Ronan, BC Ip, E Nguyen, U Widocki, T Sangpo, A Kalathungal, ... Cancer Research 84 (6_Supplement), 4724-4724, 2024 | | 2024 |
| Assessing cancer drug combination efficacy across 900+ PRISM cell lines in a multiplexed screening assay AB George, S Nair, M Kocak, E Nguyen, A Kalathungal, A Fazio, C Ponsi, ... Cancer Research 84 (6_Supplement), 4560-4560, 2024 | | 2024 |
| Creating a living public oncology drug resource using PRISM cell line viability screening MG Rees, M Kocak, C Mapa, D Frederick, E Nguyen, A Kalathungal, ... Cancer Research 84 (6_Supplement), 2106-2106, 2024 | | 2024 |
| Identifying therapeutic mechanism of action and new potential patient populations using PRISM E Nguyen, S Nair, J Davis, A Masciotti, C Mochi, J Finn, C Ponsi, B Engel, ... Cancer Research 83 (7_Supplement), 2748-2748, 2023 | | 2023 |
| DDEL-17. POOLED CANCER CELL SCREENING IDENTIFIES GENOMIC DETERMINANTS OF NANOPARTICLE DELIVERY TO CANCER CELLS: SUB ANALYSIS OF CENTRAL NERVOUS SYSTEM TUMOR CELL LINES J Straehla, N Boehnke, H Safford, M Kocak, M Rees, M Ronan, ... Neuro-Oncology 24 (Supplement_7), vii97-vii97, 2022 | | 2022 |
